ABSTRACT
Abstract Objective Our study compared the effects of injectable platelet-rich fibrin (i-PRF) with those of corticosteroids in the treatment of erosive oral lichen planus (EOLP). Methodology This split-mouth study included 24 individuals diagnosed histopathologically with bilateral EOLP. One bilateral lesion was injected with i-PRF, whereas the other was injected with methylprednisolone acetate in four sessions at 15-day intervals. Visual analog scale (VAS) for pain and satisfaction, oral health impact profile scale-14, and the lesion size were used. Results The intragroup comparisons showed a significant decrease in VAS-pain and lesion size in both the i-PRF group (from 81.88±17.74 to 13.33±18.34, and from 4.79±0.41 to 1.88±1.08, respectively) and the corticosteroid group (from 80.21±17.35 to 23.33±26.81, and from 4.71±0.46 to 2.21±1.35, respectively) in the 6th month compared to baseline (p<0.001). Moreover, VAS-satisfaction increased significantly in both the i-PRF group (from 26.67±17.8 to 85.63±16.24) and the corticosteroid group (from 28.33±17.05 to 74.38±24.11) in the 6th month compared to baseline (p<0.001). However, no significant difference in any value occurred in the intergroup comparisons. Conclusion In patients with EOLP, both methods decreased pain and lesion size similarly, and both increased satisfaction. Therefore, the use of i-PRF may be considered an option in cases refractory to topical corticosteroid therapy. Biochemical and histopathological studies are required to reveal the mechanism of i-PRF action in EOLP treatment.
Subject(s)
Humans , Lichen Planus, Oral/drug therapy , Platelet-Rich FibrinABSTRACT
Introduction: Nowadays, there are many articles about Platelet Rich Plasma/Platelet Rich Fibrin families. A novel platelet-rich product called titanium prepared platelet-rich fibrin (T-PRF) has stronger and thicker fibrin than that of the classic glass tube prepared platelet-rich fibrin. Strong fibrin structure is important to extend the time for resorption of fibrin in-vivo, and increase the release time of growth factors. Objective: In this preliminary study of a new centrifugation method, we aimed to change the direction of fibrin formation during the platelet aggregation, and make T-PRF much denser and more resistant. According to our hypothesis, it can make it possible to use in guided bone, and guided tissue regeneration more successfully. Methods: Blood samples of 10 healthy male volunteers were collected, and four 10ml blood samples, one for each of four groups, were transferred to a Ti tube from each volunteer. The first group was centrifuged for a 20-minute period clockwise (T-PRF group), and the other groups were centrifuged for a total of 20 minutes with two-minute (2min MT-PRF group), five-minute (5 min MT-PRF group), and ten-minute (10min MT-PRF group) periods clockwise and counter-clockwise. Results: By hematoxylin and eosin stain, the 10min MT-PRF group showed a better-organized network with continuous integrity compared to the other groups. With the immunofluorescent staining, fibrin seemed thicker and better organized in the 10 min MT-PRF group. SEM examination showed more complex and denser fibrin clusters in the 10 min MT-PRF group than the other groups. Conclusion: This pilot study defines 10 min MT-PRF as a new autogenous product with superior fibrin network. Our results showed that, fibrin formation was made more organised and denser with 2-way direction centrifugation.